A new era in mental health. A new era in leadership.
After half a century of being relegated to the edges of the mental health industry and social acceptance, the benefits and business of psychedelic therapy are again being given the attention and resources they deserve.
With a number of companies being formed and many going public in 2020 and 2021, the need for exceptional executive leadership and board talent in this rapidly emergent industry is critical to organizations viability and ultimate success to navigate the often unpredictable path of clinical development.
Deep industry-knowledge. A proven track record of executive search success. Exceptional candidates.
Leveraging decades of expertise in building top executive teams and boards in the pharmaceutical and early-stage biotech industries, Bedford Group Transearch has positioned themselves as a leader in helping psychedelic medicine-based organizations.
Why the Bedford Group TRANSEARCH?
Demonstrated experience in helping to shape the senior leadership teams of some of the current market leaders in this nascent space allow us to provide invaluable insights, inclusive of deep connections with key professionals and thought leaders in the neuroscience and CNS therapeutic areas. Our team of experts has a deep understanding of the current and emerging trends and deploys this insight to support the needs of our psychedelic medicine clients with their most critical executive hires and strategic talent requirements.
Learn more about our work in psychedelic medicine.
Recent executive roles we have completed for our Psychedelic Medicine clients:
- Chief Executive Officer
- Chief Financial Officer
- Chief Scientific Officer
- Chief Medical Officer
- Chief Human Resources Officer
- Vice President, Investor Relations
- Vice President, Business Development